7JJ Diez,P Iglesias.The role of the novel adipocyte-derived hormone adiponectin in human diseaseEuropean Journal of Endocrinology,2003.
8M Furuhashi,N Ura,K Higashiura,H Murakami,M Tanaka,N Moniwa.Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertensionJournal of Hypertension,2003.
9Berg AH,Scherer PE.Adipose tissue, inflammation, and cardiovascular diseaseCirculation Research,2005.
10Kumada M,Kihara S,Ouchi N,et al.Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophagesCirculation,2004.
3Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res, 2000,32:47-50.
4Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation, 2000,102:1296-1301.
5Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 2000,96:1723-1732.
6Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem, 2002,277:37487-37491.
7Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 2002,277:25863-25866.
8Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun, 1999,257:79-83.
9Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000,20:1595-1599.
10Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadi-ponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 2003,23:85-89.
3Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and othermarkers of inflammation in the prediction of cardiovascular disease inwomen[J]. N Engl Jned, 2000,342(12) :836-843.
4Nakamura Y, Shimada K, Fukuds D, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery dis- ease[J]. Heart, 2004,90(5) :528-533.
5Rothenbacher D, Brenner H, Marz W, et al. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers[ J]. Eur Heart, 2005,26 (16) : 1640-1646.
6Wilson SR, Sabatine MS, Wiviott SD. Assessment of adiponeetin and the risk of reeurrent eardiovasenlar events in patients presen- ting with an acute coronary syndrome : observations from the pravas- tatin or ator vastatin evaluation and infection trial-throlnbolysis in myoeardial infaretion 22(PROVE IT -TIMI22) [ J]. Am Heart J, 2011,161 (6) :1147-1155.
7Quchi N, Kihara S, Funahashi T, et al. Reciprocal association of creactive protein with adiponectin in blood stream and adipose tis- sue [ J ]. Circulation, 2003,107 ( 5 ) : 671-674.
8Nakamuray,Shimadak,Fukudad,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery[J].Heart,2004,90:528-533.
9Uli CB,Corinna L,Michael L,et al.Low Adiponectin Levels Are an Independent Predictor of Mixed and Non-Calcified Coronary Atherosclerotic Plaques[J].Plos ONE,2009,4(3):e4733.
10Darid S,Frankel,Ramachandran S,et al.Resistin,adiponectin and risk of heart failure,the Framimgham off-spring study[J].J Am Coll Cardiol,2009,53:754-760.
